Introduction
Recent studies have revealed that vascular endothelial growth factor (VEGF), also referred to as vascular permeability factor (VPF), is an important element for many angiogenic processes in normal and abnormal states such as diabetic retinopathy and tumor vascularization (Folkman, 1990; Ferrara et al., 1991; Shibuya, 1995; Mustonen and Alitalo, 1995) . VEGF carries two major biological activities, one is the capacity to stimulate vascular endothelial cell proliferation (Ferrara and Henzel, 1989; Leung et al., 1989; Connolly et al., 1989) and the other is the ability to increase microvessel permeability to macromolecules (Senger et al., 1983; Keck et al., 1989) . In addition, VEGF was found to stimulate migration (Clauss et al., 1996) and protease production in endothelial cells (Pepper et al., 1991; Unemori et al., 1992) , migration of peripheral blood monocytes (Clauss et al., 1993; Barleon et al., 1996) and the resistance of hematopoietic cells to radiation-induced apoptosis (Katoh et al., 1995) . The mechanism underlying these diverse processes is still not well characterized.
VEGF binds two tyrosine kinase receptors, Flt-1 and KDR/Flk-1 with high anity (De Vries et al., 1992; Millauer et al., 1993) . Flt-1 and KDR/Flk-1 belong to a receptor gene family distantly related to Fms/Kit/PDGF receptor, and share 7-immunoglobulin (Ig)-like domains in the extracellular domain and a long kinase insert in the middle of the kinase domain (Shibuya et al., 1990; Matthews et al., 1991; Terman et al., 1992) . Since the mRNAs of the Flt-1 and KDR/ Flk-1 are speci®cally expressed in the vascular endothelial cells (Jakeman et al., 1993; Eichmann et al., 1993; Kaipainen et al., 1993; Quinn et al., 1993; Yamane et al., 1994) , VEGF has been considered to be in most cases only relevant to the vascular system.
It is obviously important to know whether VEGF and its receptors utilize endothelial cell-speci®c signal transduction pathway(s) for mitosis and dierentiation. Recently, PLC-g, Nck, PI 3 kinase and GAP have been reported to be tyrosine phosphorylated in endothelial cells in the presence of VEGF (Guo et al., 1995) . Other groups showed that paxillin and FAK were tyrosinephosphorylated in response to VEGF in human umbilical vein endothelial cells (HUVEC) (Abedi and Zachary, 1997) . However, it remains to be elucidated which signal transduction pathways are essential for VEGF-induced cell growth and dierentiation.
Further, it is an open question whether the Flt-1 and KDR/Flk-1 tyrosine kinases phosphorylate and activate similar or very dierent substrates within the cell. Recent studies on the targeting of these two VEGF receptor genes demonstrated that KDR/¯k-1-minus homozygous mice are lethal at 8.5 ± 9.5 embryonic days due to the lack of endothelial cell growth and blood vessel formation, as well as an extremely poor hematopoiesis (Shalaby et al., 1995) . On the other hand,¯t-1-minus homozygous mice are also lethal at the same stage but this is due to overgrowth of endothelial cells and disorganization of blood vessels (Fong et al., 1995) . These ®ndings suggest that at least at the early stage of embryogenesis, KDR/Flk-1 stimulates the proliferation of endothelial cells and Flt-1 is required more for dierentiation and vascular organization. However, the biochemical processes that underlie these signaling pathways remain largely unknown.
We have previously reported that KDR/Flk-1 is highly phosphorylated on tyrosine residue and that one of the major target molecules of KDR/Flk-1 is PLC-g, which binds to the KDR/Flk-1 and is tyrosinephosphorylated in response to VEGF . It seems likely that the activated PLC-g stimulates hydrolysis of phosphatidyl inositol (PIP 2 ), leading to protein kinase C (PKC) activation and Ca 2+ mobilization. We have also shown that MAP kinase was activated upon VEGF stimulation both in NIH3T3 cells overexpressing KDR/Flk-1 (NIH3T3-KDR cells) and in sinusoidal endothelial (SE) cells. In NIH3T3-KDR cells, VEGF-induced MAP kinase was mainly mediated by PKC. Recently, Xia et al. have reported that a PKCb inhibitor strongly suppressed VEGF-dependent endothelial cell growth (Xia et al., 1996) . However, the role of PKC and the signi®cance of other pathways such as Ras in the VEGF signaling in endothelial cells are still not extensively studied.
In the present study, we show that VEGF activates Raf-MEK-MAP kinase pathway in primary SE cells. We also demonstrate that the signals from VEGF receptors to MAP kinase are mainly mediated by PKCdependent pathway, and to a lesser extent by Rasdependent of PI 3 kinase-dependent pathway and that the PKC-dependent pathway is essential for stimulation of DNA synthesis in primary endothelial cells. Among the PKC isoforms, we also suggested the involvement of PKCb isoform in the VEGF signaling.
Results

VEGF activates Raf-MEK-MAP kinase pathway
Previously we have shown that MAP kinase as well as PLC-g is activated by VEGF stimulation not only in NIH3T3-KDR cells but also in primary sinusoidal endothelial (SE) cells from a rat liver . Although MAP kinase functions in a signaling downstream of Ras, Raf-1 and MEK, other multiple pathways may converge at MAP kinase. Thus, at ®rst, we examined whether VEGF-induced activation of MAP kinase is MEK-dependent or not, by using a MEK-1 inhibitor, PD98059. As shown in Figure 1a and b, VEGF induced signi®cant activation of PLC-g and MAP kinase on SE cells. When SE cells were pretreated with PD98059 prior to VEGF stimulation, PD98059 severely abolished VEGFinduced activation of MAP kinase at a concentration of more than 50 mM, at which PD98059 could inhibit activation of MEK-2 as well as MEK-1 (Alessi et al., 1995) . Furthermore, PD98059 inhibited VEGF-induced proliferation of SE cells, although autophosphorylation of Flk-1/KDR and tyrosine phosphorylation of PLC-g were not impaired in these cells (data not shown). Thus, we suggest that VEGF-induced activation of MAP kinase as well as cell proliferation are mainly dependent on MEK-1/2.
These results prompted us to examine directly VEGF-induced activation of MEK and Raf-1, which are expected to function upstream of MAP kinase. As shown in Figure 1c , we con®rmed MEK-1/2 were phosphorylated in response to VEGF by using antiphospho-speci®c MEK-1/2 antibody. Raf-1 activity was measured by immune-complex assay using (His) 6 -MEK and kinase inactive GST-MAP kinase as substrates. Raf-1 was also activated by VEGF stimulation (Figure 1d ). Kinetics in the activation of both MEK-1/2 and Raf-1 were almost consistent with those in the activation of MAP kinase with a peak of 5 min after VEGF stimulation and a rapid decline within 15 min. Therefore, we conclude that the activation of Raf-1-MEK-MAP kinase pathway is involved deeply in VEGF signaling. 
Ras activation is not required for VEGF-induced mitosis in SE cells
Many tyrosine kinases, including the receptors for EGF, PDGF and NGF, transmit intracellular signals through Ras protein (Muroya et al., 1992; Satoh et al., 1990a, b; Qiu and Green, 1991) . These ligands stimulate Ras guanine-nucleotide-exchange activity and increase the level of GTP-bound Ras converting from GDP-bound one. Thus we next examined whether Ras is activated in response to VEGF stimulation in SE cells. Unexpectedly, as shown in Figure 2a , VEGF-induced Ras-GTP complex was almost undetectable.
To con®rm this, we transfected dominant negative mutant of Ha-Ras (Ha-Ras57Y) (Jung et al., 1994) into SE cells using adenoviral vector (Miyake et al., 1996; , and examined whether the activation of Ras is required for VEGF-induced phosphorylation of MAP kinase and cell proliferation. Ha-Ras57Y was previously shown to eciently suppress the activation of MAP kinase and DNA synthesis in rat aortic smooth muscle cells stimulated with fetal bovine serum . We also con®rmed the dominant inhibitory eect of HaRas57Y on Ras-MAP kinase pathway by showing that the PDGF-induced MAP kinase phosphorylation is markedly inhibited by Ha-Ras57Y in NIH3T3 cells (Figure 3a , right panel).
When SE cells were infected with adenovirus containing the dominant negative mutant Ha-Ras57Y at moi 100, they expressed markedly elevated levels of Ras protein as compared with the uninfected (data not shown) and control cells (Figure 3a, left panel) . In spite of the overexpression of this mutant, neither VEGFinduced phosphorylation of MAP kinase, cell proliferation nor morphological changes were apparently aected (Figure 3a, left panel and b) . Essentially the same results were obtained by using the adenoviral vector expressing another, classical type of dominant negative mutant Ki-Ras17N. This dominant negative mutant of Ki-Ras also suppressed PDGF-induced phosphorylation of MAP kinase but could not signi®cantly suppress VEGF-induced MAP kinase phosphorylation in SE cells (data not shown).
In addition, we could not ®nd non-speci®c eects of adenoviral infection, because the growth curve and morphology of SE cells infected with control adenovirus (AdLacZ) were essentially the same as those of uninfected (mock) SE cells. These results indicate that activation of Ras is not required for the VEGF signaling towards cell proliferation in SE cells.
Consistent with these data, we previously reported that Shc, which is an important adapter protein linking tyrosine kinase to Ras, was not signi®cantly phosphorylated nor associated with the phosphorylated KDR/Flk-1 in SE cells in response to VEGF (Seetharam et al., 1995) . Thus, we next examined whether another adapter protein, Grb2 was associated with the phosphorylated KDR/Flk-1 in response to VEGF. As shown in Figure 2b , we could not ®nd VEGF-induced association of Grb2 with the Shc or KDR/Flk-1, while in NIH3T3 cells overexpressing EGF receptors (EGFR) , Grb2 was associated with the phosphorylated Shc and EGFR in response to EGF. Protein kinase C inhibitor blocks the VEGF-induced Raf-MEK-MAP kinase pathway and subsequent DNA synthesis
We have previously reported that one of the major target molecules of KDR/Flk-1 is PLC-g, which binds to KDR/Flk-1 and is tyrosine-phosphorylated in response to VEGF . Furthermore we showed that in NIH3T3-KDR cells, VEGF-induced activation of MAP kinase is mainly mediated by protein kinase C (PKC). However, in endothelial cells, whether PKC is involved in VEGF signaling remains unclear. To access the role of PKC, we used several PKC inhibitors on SE cells and examined their eects on the activation of MAP kinase and subsequent DNA synthesis as well as the electric mobility shift of Raf-1. As in the case of CSF-1 (Baccarini et al., 1990) or insulin (Izumi et al., 1991) stimulation, we observed VEGF-induced electric mobility shift of Raf-1, indicating the activation of Raf-1 (Figure 4a ).
Recently GF109203X (GFX) has been reported as a highly selective and potent PKC inhibitor, which is structurally related to staurosporine (Toullec et al., 1991) . When the SE cells were pretreated with GFX, VEGF-induced electric mobility shift of Raf-1 ( Figure  4a ) and activation of both MEK and MAP kinase (Figure 4b and c, respectively) were severely suppressed. Furthermore, to evaluate the eect of GFX on DNA synthesis, we examined thymidine incorporation into SE cells. In SE cells stimulated with VEGF, GFX strongly inhibited thymidine incorporation compared with control cells (Figure 4d) .
To con®rm the speci®city of the inhibitory eect of GFX on PKC in SE cells, we have examined the tyrosine phosphorylation and activation of other kinases such as Flk-1/KDR and PLC-g. We could (AdRas57Y) by using adenoviral vectors. After 2 days, cells were starved for 6 h without VEGF and then unstimulated or stimulated with VEGF for 5 min (left panels). NIH3T3 cells were also starved for 6 h in DMEM-0.1% CS and unstimulated or stimulated with PDGF for 5 min (right panels). Cell lysates were analysed by SDS ± PAGE, transferred onto Immobilon and blotted with antibody speci®c for either phosphoMAP kinase, p44/42 MAP kinase or Ha-Ras as indicated in the ®gure. (b) SE cells were cultured in the presence of VEGF and infected with either AdLacZ or AdRas57Y at the ®rst day of culture. The cells were ®xed with 3% paraformaldehyde and stained with crystal violet at the ®rst and the fourth day of culture Figure 4 Protein kinase C-speci®c inhibitor blocks VEGFinduced phosphorylation of Raf-MEK-MAP kinase pathway and subsequent DNA synthesis. SE cells were stimulated without or with VEGF after pretreatment of only DMSO or GF109203X (GFX) in DMSO for 1 h. Total cell lysates were analysed by Western blotting using antibody speci®c for either Raf-1 (a), phosphoMEK1/2 or MEK (b), or phosphoMAP kinase or p44/42 MAP kinase (c) as indicated in the ®gure. Alternatively, SE cells were pulse-labeled with 3 H-thymidine (1 mCi/ml) for 4 h. Then they were harvested on glass ®lters and incorporated radioactivity was measured. Data represented the average of triplicate samples (d) not ®nd a signi®cant inhibitory activity of GFX on these protein kinases except for PKC (data not shown).
We also tested conventional PKC isoform-speci®c inhibitor, GoÈ 6976, which preferentially suppresses the activity of PKCa, b and g isoforms (Martiny- Baron et al., 1993) . When SE cells were pretreated with GoÈ 6976, both VEGF-induced activation of MAP kinase and thymidine incorporation were strongly inhibited, similar to the cases of GFX (data not shown). These ®ndings suggest that VEGF-induced activation of MAP kinase requires PKC-dependent pathway and that VEGF-stimulated thymidine incorporation is under the control of PKC, preferentially conventional PKC isoforms.
VEGF stimulates intracellular translocation of PKC isoforms
Since the activation of some PKC isoforms is associated with their intracellular translocation (Mochly-Rosen, 1995), we assessed their intracellular distribution by immunoblotting with isoform-speci®c antibodies. In quiescent control SE cells, PKCa and PKCg were detected primarily in the cytosolic fraction. After an incubation with TPA for 15 min, most of these isoforms translocated into the particulate fraction. However, on stimulation with VEGF for 5 min, no signi®cant translocation was observed in either PKCa or PKCg. On the other hand PKCb isoform was detected in both cytosolic and particulate fractions in quiescent SE cells. When SE cells were stimulated with VEGF, a signi®cant amount of PKCb translocated into the particulate fraction as seen in the cells stimulated with TPA ( Figure 5 ). This suggests that PKCb isoform is preferentially activated in response to VEGF in SE cells. We also observed no signi®cant translocation in other PKC isoforms such as PKCd, e, i, m, l and y after the stimulation with VEGF (data not shown).
Activation of PI 3 kinase is not essential for VEGF signaling to DNA synthesis Recently Flt-1 kinase has been shown to associate with p85 subunit of PI 3 kinase when these molecules were overexpressed in yeast cells (Conningham et al., 1995) . It is not clear yet whether or not this interaction is biologically signi®cant in primary endothelial cells. To address the question of whether PI 3 kinase is involved in VEGF signaling, we used an inhibitor of PI 3 kinase, Wortmannin, and examined its eect on VEGFinduced phosphorylation of MAP kinase and on DNA synthesis. As shown in Figure 6 , neither VEGF-induced phosphorylation of MAP kinase nor DNA synthesis was aected by the treatment of Wortmannin even at a concentration of 1 mM. Another PI 3 kinase inhibitor, LY294002 had also no eect on VEGF-induced phosphorylation of MAP kinase (data not shown). In addition, tyrosine phosphorylation of PI 3 kinase subunit p85 was undetectable in SE cells after stimulation of VEGF (data not shown). Therefore, the major part of VEGFdependent MAP kinase activation and DNA synthesis were not dependent on PI 3 kinase in SE cells.
A PKC activator, TPA mimics a major part of the angiogenic eect of VEGF on SE cells in vitro PKC activator such as TPA is known to substitute for DAG and therefore may bypass the normal signaling initiated by the binding of ligands to the receptors (Nishizuka, 1992) . To con®rm the implication of PKC in SE cells, we examined whether TPA stimulates DNA synthesis and morphological changes of SE cells as in Figure 5 VEGF eects on the intracellular translocation of protein kinase C isoforms. SE cells were unstimulated or stimulated with VEGF or with TPA and each sample was fractionated into particulate (P) and cytosolic (C) fractions as mentioned in Materials and methods. Cells were lysed and resolved by Western blotting and probed with monoclonal antiPKCa, PKCb or PKCg antibody 3 H-thymidine (1 mCi/ml) for 4 h. Then they were harvested on glass ®lters and incorporated radioactivity was measured. Data represent the average of triplicate samples the case of VEGF stimulation. When tested at concentration ranging from 0.2 ± 2000 nM, TPA clearly stimulated DNA synthesis in SE cells in a dose-dependent manner, whereas a rather slight inhibitory eect was observed in NIH3T3 cells used as a control (Figure 7a ). In addition, GFX abolished TPA-induced DNA synthesis, indicating that the eect of TPA is largely attributed to the activation of PKC (data not shown). We also observed morphological changes in TPA-treated SE cells, similar to the cases of VEGF-stimulated cells (Figure 7b ). So far, only VEGF and TPA but no other growth factors such as basic FGF or EGF stimulated proliferation and morphological alteration of SE cells (Yamane et al., 1994) . While most VEGF-stimulated SE cells could not survive for 1 week, TPA-stimulated SE cells lived longer. The molecular mechanism of this long-term survival of SE cells with TPA is not clear at this time, but it might be due to a continuous action of PKC pathway with TPA, or due to an anti-apoptotic eect of TPA.
Therefore, taken together, we strongly suggest that the activation of PKC accounts for VEGF-induced DNA synthesis and morphological changes, which are the most important part of the biological eect of VEGF.
Discussion
In this study, we showed that VEGF stimulates PLC-g-PKC pathway and Raf-1-MEK-MAP kinase cascade in primary sinusoidal endothelial (SE) cells. However, to our surprise, VEGF-induced Ras-GTP complex formation was almost undetectable in SE cells. Consistent with this, expression of dominant negative Ras had no suppressive eect on VEGF-induced phosphorylation of MAP kinase or cell proliferation. In addition, our previous studies and preliminary data revealed that Grb2 and Shc, important components linking tyrosine kinase to Ras, were not strongly involved in VEGF signaling, since the phosphorylated KDR/Flk-1 was not associated with Grb2 or Shc, and Shc was not tyrosine-phosphorylated to a signi®cant level upon VEGF stimulation in SE cells (Figure 2b , Seetharam et al., 1995; Takahashi et al., unpublished) . Recently, another group reported that Shc is tyrosine-phosphorylated and associated with Grb2 in response to VEGF in arti®cially KDR-overexpressing porcine aortic endothelial cells, suggesting KDR/Flk-1 activates the Ras pathway (Kroll and Waltenberger, 1997) . However, these authors did not examine directly the VEGFinduced Ras-GTP formation or the eects of dominant negative mutant Ras on MAP kinase activation or on cell proliferation. Nevertheless, we could not completely rule out a possibility that this discrepancy is attributed to the endothelial cell background obtained from dierent tissues.
In general, many tyrosine kinases including the receptors for EGF, PDGF and NGF, are well known to transmit intracellular signals mainly through activation of Ras (Muroya et al., 1992; Satoh et al., 1990a, b; Qiu and Green, 1991) . Thus, the VEGF receptors are unique in the view that the major growth signal is not mediated by Ras, but transduced by PLCg-PKC pathway.
In endothelial cells, however, Ras possibly transduces another type of signal, such as mechanical stimuli, to nuclei. Recently, Li et al. reported that the shear stress clearly activated Ras and subsequent Jun kinase pathway in HUVEC (Li et al., 1996) . Therefore, in a distinct cell background, Ras appears to be utilized for the transduction of dierent stimuli; mostly mitotic signal in epithelial cells and ®broblasts, dierentiation or mitotic signals in neuronal cells and at least mechanical signals in endothelial cells.
Another important signi®cant pathway independent of Ras, JAK-STAT system seems not to be deeply involved in VEGF signaling, since tyrosine-phosphorylation of JAK1, JAK3, STAT1, STAT3 and STAT5 was almost undetectable upon stimulation with VEGF (data not shown). In addition, the expression of JAK2 was almost undetectable at protein levels in SE cells (data not shown).
PKC is a key regulatory enzyme involved in many cellular processes (Nishizuka, 1992) . Previously, PKC was reported to be important for vasculoendothelial Hthymidine (1 mCi/ml) for 4 h. Then they were harvested on glass ®lters and incorporated radioactivity was measured. The radioactivity of stimulated with vehicle alone has been arbitrarily de®ned as 1. Data represent the average of triplicate samples. (b) TPA mimics VEGF-induced morphological changes in SE cells. SE cells were unstimulated, or stimulated with 10 ng/ml VEGF or 200 nM TPA and incubated for the indicated periods. The cells were ®xed with 3% paraformaldehyde and stained with crystal violet system, because activation of PKC by phorbol ester such as TPA, induced proliferation (Daviet et al., 1989) and tube formation (Montesano and Orci, 1985) of cultured endothelial cells to some extent, and caused angiogenesis in vivo (Morris et al., 1988) . Phorbol esters, however, are not physiological substances to cells, thus, it was dicult to imagine what kind of an angiogenic factor(s) utilizes PKC-dependent pathway under the physiological condition. In the present study, we demonstrated that VEGF greatly stimulated the PLC-g-PKC pathway and DNA synthesis of cultured SE cells, whose growth is strictly dependent on VEGF, but not bFGF nor EGF. Furthermore, TPA induced DNA synthesis in these cells. These results indicate that activation of PKC plays a fundamental role in VEGF-dependent endothelial cell growth. That PKC is involved in endothelial cell growth was further con®rmed by the inhibitory eect of GF109203X (GFX), which has recently been established as a potent and speci®c inhibitor of PKC (Toullec et al., 1991) . GFX eciently blocked both phosphorylation of MEK and MAP kinase and DNA synthesis induced by VEGF in primary SE cells. These results are consistent with the essential role of PKC in the endothelial cell growth.
Based on the molecular analysis, the PKC family is thought to comprise about ten functionally related but structurally distinct isoforms, all with discrete cofactor requirement, substrate speci®city and tissue distribution (Nishizuka, 1992) . Although each isoform is expected to perform distinct functions in vivo, little is known about these functions at present. Several lines of evidence suggested that an abnormal activation of PKC, preferentially PKCb isoform, is implicated in the development of vasculoendothelial complications in some pathological conditions (Inoguchi et al., 1992; Wolf et al., 1991) . Furthermore, a recent report by Xia et al. has indicated that PKCb-speci®c inhibitor could suppress the VEGF-induced proliferation of endothelial cells (Xia et al., 1996) . Together with our results shown here, these ®ndings suggest that activation of PKCb isoform plays the major role in the mitotic signaling in endothelial cells. However, whether or not the PKCb is essential for physiological angiogenesis in vivo should be clari®ed by further analysis.
Recently some PKC isozymes have been reported to activate the MAP kinase pathway in cultured cells other than endothelial cells. PKCa isozyme was shown to activate Raf-1 by direct phosphorylation (Kolch et al., 1993) . Ueda et al. (1996) showed that PKCd is a possible activator of the MAP kinase pathway in COS cells in a Ras-independent manner, by using a constitutively active mutant of PKCd. In a recent report, PKCe was implicated in signaling of cell proliferation by activating Raf-1 in NIH3T3 cells (Cai et al., 1997) . Similar to this report, in NIH3T3-KDR cells a preferential translocation of PKCe, but not PKCb, was observed in response to VEGF (data not shown). In a recent study, we found that the NIH3T3-KDR cells showed only a slow response of MAP kinase activation and a weak stimulation of cell growth in the presence of VEGF when compared to endothelial cells . Thus, we suggest that distinct subsets of PKCs are utilized in VEGF signaling in other cell types such as ®broblasts arti®cially expressing VEGF receptors.
Our results indicate that conventional PKCs, possibly PKCb, may activate Raf-1 in primary endothelial cells. In a recent study, PKCb was found to activate Raf-1 in in vitro kinase assay (SoÈ zeri et al., 1992) . Based on these reports, we consider that under certain conditions, either directly or indirectly, PKCb activates MAP kinase through activation of Raf-1 and MEK. It would be interesting to examine biochemically how a PKC isoform interacts and activates Raf-1 kinase downstream of VEGF receptors.
Whether PI 3 kinase is involved in VEGF signaling is still controversial. Some groups reported that PI 3 kinase is activated in response to VEGF (Guo et al., 1995; Xia et al., 1996) and others that it is not (Waltenberger et al., 1994) . Recently Flt-1 kinase has been shown to associate with p85 subunit of PI 3 kinase when these molecules are overexpressed in yeast cells (Conningham et al., 1995) . However, it is not clear whether this interaction takes place in primary endothelial cells, because the Flt family receptors do not have tyrosine residues of the recognition motif for PI 3 kinase (tyrosine-X-X-methionine) within the kinase insert nor in the carboxyl tail. As far as signaling to DNA synthesis is concerned, we suggest that PI 3 kinase is not involved in VEGF signaling, since potent PI 3 kinase inhibitor, Wortmannin had no eects on VEGF-induced activation of MAP kinase or DNA synthesis. However, we cannot rule out a possibility that a weak activation of PI 3 kinase pathway by VEGF is involved in other responses of endothelial cells to this ligand, such as cell migration and gene expression.
In conclusion, our ®ndings strongly suggest that VEGF receptor tyrosine kinases activate PLC-g and utilize its enzymatic product diacylglycerol for activation of PKC-Raf-1-MEK-MAP kinase pathway as the major signaling towards cell proliferation. Among VEGF receptors, KDR/Flk-1 appears to be responsible for most of this signaling, since Flt-1 carries a very weak tyrosine kinase activity (Seetharam et al., 1995; Waltenberger et al., 1994; Sawano et al., 1997) .
Materials and methods
Cell cultures and growth factors
Sinusoidal endothelial (SE) cells were isolated from a rat liver as described and grown in HuMedia-EG2 medium (Kurabo, Osaka) supplemented with VEGF (10 ng/ml) (Yamane et al., 1994) . NIH3T3 cells were maintained in Dulbecco's modi®ed Eagle's medium (DMEM; Nissui, Tokyo) supplemented with 10% calf serum (CS, 2 mM LGlutamine and 40 mg/ml kanamycin. 3Y1 cells overexpressing active Ha-Ras were prepared by transfection of 3Y1 cells with active Ha-Ras and cultured in DMEM supplemented with 10% fetal bovine serum, 2 mM LGlutamine and 40 mg/ml kanamycin. Recombinant human VEGF (165 amino-acid form) was puri®ed by heparin column chromatography from the conditioned medium of Sf-9 insect cells expressing the VEGF gene (Cohen et al., 1992) . Recombinant human PDGFB/B was obtained from Boehringer Mannheim (Gmnh, Germany). 
Immunoblotting and immunoprecipitation
For in vivo phosphorylation, SE cells were starved for 6 h in HuMedia-EG2 medium without VEGF and stimulated with 10 ng/ml VEGF for the indicated times at 378C. NIH3T3 cells or NIH3T3 cells overexpressing EGFR were also starved in DMEM-0.1% CS and stimulated with 10 ng/ml PDGF or EGF, respectively. The cells were washed in ice-cold phosphate buered saline (PBS)-0.1 mM Na 3 VO 4 twice and lysed in 1% Triton X-100 lysis buer [50 mM N-2 hydroxyethylpiperazine-N-2-ethane sulfonic acid (HEPES), pH 7.4, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl 2 , 2% aprotinin, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 50 mM NaF, 10 mM Na 4 P 2 O 7 and 2 mM Na 3 VO 4 ]. The lysates were clari®ed by centrifugation (15 000 r.p.m.610 min). For immunoblotting, the cell lysates were subjected to SDS ± polyacrylamide gel electrophoresis (PAGE) and transferred onto Immobilon (Millipore, Bedford, MA, USA). After transfer, the blots were incubated with the blocking solution [5% bovine serum albumin (BSA) in washing buer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.3% Tween 20)] and probed with the primary antibody diluted in the blocking solution. The signal was visualized using HRP-conjugated secondary antibodies and enhanced chemiluminescence (ECL; Amersham) according to the manufacturer's instructions.
For immunoprecipitation, cell lysates were incubated with the primary antibody and then protein A (for anti-Grb2 antiserum) or G (for anti-PLC-g antibodies) sepharose beads (Pharmacia) were added. The beads were washed ®ve times with 1% Triton X-100 lysis buer.
Assay of DNA synthesis SE cells were grown in 24-well collagen-coated culture plates and starved for 6 h in modi®ed HuMedia-EG2 medium without VEGF, in which basal medium was replaced by DMEM lacking thymidine. NIH3T3 cells were also starved in DMEM containing 0.1% CS. Cells were unstimulated, or stimulated with 10 ng/ml VEGF or 200 nM TPA. Alternatively, they were incubated with various inhibitors or vehicle for 1 h prior to stimulation without or with 10 ng/ml VEGF. Then, after incubation for 16 h, cells were pulse-labeled with 3 H-thymidine (1 mCi/ ml) for 4 h. Finally, they were harvested on glass ®lters and incorporated radioactivity was measured. Data represent the average of triplicate samples.
Ras assay
Details of procedures were described elsewhere (Satoh et al., 1990a) . Brie¯y, SE cells were labeled for 6 h with 0.1 mCi/ml 32 P-orthophosphate in phosphate-free DMEM. At the end of labeling, cells were stimulated without or with 50 ng/ml VEGF for 5 min or 15 min at 378C and lysed in 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 20 mM MgCl 2 , 1% Triton X-100, 1 mM Na 3 VO 4 and protease inhibitors. The lysates were centrifuged to remove nuclei and cell debris. Immunoprecipitation was carried out by addition of monoclonal anti-Ras antibody Y13-259 coupled to anti-Rat IgG antiserum and protein A sepharose and incubation for 1 h at 48C. The beads were then washed extensively with lysis buer four times and washing buer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 20 mM MgCl 2 ) once. Elusion was carried out by addition of sample buer (20 mM Tris-HCl, pH 7.5, 20 mM EDTA and 2% SDS) and the samples were resolved on a polyethyleneimine cellulose plate. Chromatography was developed with 1 M KH 2 PO 4 , pH 3.4. Autoradiography was visualized by a Fuji BAS 2000 image analyser.
Transfection of dominant negative Ras by using a recombinant adenovirus
The adenovirus expressing either a dominant negative mutant of Ha-Ras (AdRas57Y) in which aspartic acid is replaced with tyrosine at residue 57, or the bacterial bgalactosidase (AdLacZ) were constructed as described previously (Jung et al., 1994; Miyake et al., 1996; . Another type of the adenovirus expressing dominant negative Ki-Ras17N containing an asparagine substitution at position 17 of Ki-Ras (AdRas17N) was kindly provided by Drs Yoshitomo Oka and Hideki Katagiri (Yamaguchi University and University of Tokyo, respectively) (Katagiri et al., 1997) . SE cells or NIH3T3 cells were incubated with Hank's solution containing either AdRas57Y, AdRas17N or AdLacZ for 1 h at room temperature and then cultured for 2 or 3 more days.
Raf-1 kinase assay
Cell lysates were prepared as described above. The cell lysates were immunoprecipitated with anti-Raf-1 antibody and protein A sepharose beads, which were incubated for 30 min in advance. After intensive washing, immunecomplex kinase assay was performed for 20 min at 308C in a reaction mixture containing 20 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM MgCl 2 , 1 mM MnCl 2 , 200 mM ATP and 0.5 mCi [g-32 P]ATP in the presence of (His) 6 -MEK and kinase inactive GST-MAP kinase as substrates. Reaction was stopped by adding sample buer and supernatants were analysed by SDS ± PAGE.
In gel kinase assay of MAP kinase
The separating gels were polymerized with 0.5 mg/ml of myelin basic protein (MBP; Sigma). Samples containing 15 mg of protein were subjected to SDS ± PAGE. Then the gels were denatured in 6 M guanidine-HCl, renatured and assayed for kinase activity as described previously (Gotoh et al., 1990) .
Intracellular distribution of PKC isoforms
After SE cells were unstimulated or stimulated with 50 ng/ ml VEGF for 5 min or 200 nM TPA for 15 min at 378C, they were scraped, collected in extraction buer (50 mM HEPES-OH, pH 7.5, 10 mM NaCl, 10 mM EDTA, 0.25 M Sucrose, 1 mM Na 3 VO 4 , 10 mM NaF and protease inhibitors) and disrupted mechanically in a Dounce homogenizer. The homogenates were centrifuged at 1000 g for 10 min at 48C to remove nuclei and undisrupted cell debris. The supernatant was saved and ultracentrifuged again at 100 000 g for 1 h at 48C. The supernatant was saved as the cytosolic fraction and the pellet was resuspended in the extraction buer plus 1% Triton X-100. The latter samples were again subjected to centrifugation to remove insoluble materials. This resultant supernatant was also saved as the particulate fraction.
